About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04896866

Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)

COVID-19 is respiratory disease caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2), a novel coronavirus which has spread rapidly across the world with over 149.9 million laboratory conf...

Lead sponsor: University of Alberta•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

University of Alberta

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age ≥18 years at the time of hospital admission.
•Confirmed SARS-CoV-2 infection by nucleic acid testing in the preceding 14 days of hospital admission.
•Admitted from the community (including continuing care facilities).
•Admitted to a hospital bed designated in the study.
•SpO2 ≤94% requiring supplemental oxygen or chest imaging findings compatible with COVID-19 pneumonia.

Exclusion Criteria

•The patient is enrolled in another clinical trial that involves antibacterial therapy.
•The patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission.
•The patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission.
•The patient was attended by any member of the research team within 30 days of enrollment.
•The patient is transferred from another acute care center.

Related studies

RECRUITINGPhase 2

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

NCT06402318 · COVID-19, SARS CoV 2 Virus, and more

The Effect of the Covid-19 Pandemic Among Operated Patients

NCT04525716 · Covid19, Surgery

RECRUITINGPhase 3

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

NCT03188796 · Critical Illness, Vitamin D Deficiency, and more

COVID-19 Survivorship Registry

NCT04527315 · Covid19

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 19, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment833

Start dateMar 2021

Last updatedSep 19, 2024

Condition

Covid19 COVID-19 Pneumonia COVID-19 Lower Respiratory Infection COVID-19 Acute Respiratory Distress Syndrome SARS-CoV2 Infection+1 more

Locations shown

Misericordia Community Hospital

Edmonton, Alberta

University of Alberta Hospital

Edmonton, Alberta

Grey Nuns Community Hospital

Edmonton, Alberta

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions